专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

AU2020103519A4 IFAC- Driver Less Vehicle: Driver Less Intelligent Fully Autonomous Controlled Vehicle 未知
公开(公告)号：AU2020103519A4
公开(公告)日：2021-01-28
申请号：AU2020103519
申请日：2020-11-18
申请人： BHASKAR ZOPE SANJAY , CHORDIYA S B , JAIN VIPIN , KUMARI SWATI , RAJESH B , RAVI C N , REDDY B SUDHAKAR , REZNIK NADIA P , SRUJANA A , VISHRAM REVANKAR ANIL , KUMAR M VIJAY
发明人： SRUJANA A , KUMARI SWATI , RAVI C N , REDDY B SUDHAKAR , RAJESH B , KUMAR M VIJAY , VISHRAM REVANKAR ANIL , BHASKAR ZOPE SANJAY , REZNIK NADIA P , CHORDIYA S B , JAIN VIPIN
IPC分类号： G05D1/02 , B60W60/00
摘要： Our invention "IFAC- Driver Less Vehicle" is a method and computer program product intelligently drives a IFAC- driver less vehicle to a service facility and one or more processors receive sensor readings from a IFAC- driver less vehicle equipment maintenance sensor on the IFAC- driver less vehicle. The IFAC- driver less vehicle equipment maintenance sensor detects a state of equipment on the IFAC- driver less vehicle indicative of a need for maintenance service for the IFAC- driver less vehicle and the processor(s) identify a service facility capable of providing the maintenance service and determine an amount of time required for the IFAC- driver less vehicle to travel to and from a current location of the IFAC- driver less vehicle to the service facility and to receive the maintenance service. The IFAC- driver less vehicle also include the processors identify a time window in which a user of the IFAC- driver less vehicle will not need the IFAC- driver less vehicle and then direct the IFAC- driver less vehicle to autonomously drive to the service facility during the time window in which the user of the IFAC- driver less vehicle will not need the IFAC- driver less vehicle. The IFAC- driver less vehicle comprises an IFAC- driver less vehicle equipment maintenance sensor a processor a computer readable memory, and a non-transitory computer readable storage medium. Stored on the non-transitory computer readable storage medium are first program instructions to receive sensor readings from an IFAC- driver less vehicle equipment maintenance sensor on the IFAC- driver less vehicle, where the IFAC- driver less vehicle equipment maintenance sensor detects a state of equipment on the IFAC- driver less vehicle indicative of a need for maintenance service. The IFAC- driver less vehicle second program instructions to identify a service facility capable of providing the maintenance service and third program instructions to determine an amount of time required for the IFAC- driver less vehicle to travel to and from the service facility to a current location of the IFAC- driver less vehicle and to receive the maintenance service and fourth program instructions to identify a time window in which a user of the IFAC- driver less vehicle will not need the IFAC- driver less vehicle and fifth program instructions to direct the IFAC driver less vehicle to autonomously drive to the service facility during the time window in which the user of the IFAC- driver less vehicle will not need the IFAC- driver less vehicle. The first, second, third, fourth, and fifth program instructions are stored on the non transitory computer readable storage medium for execution by one or more processors via the computer readable memory. L*5 10 151 DM "A10 11" 16 MON 1I]0N FIG. LGI 1:R depict an7 exmlr vytmadntoki hc h rsn icouemyb implemented;1V

2. 发明申请

WO02069995A3 USE OF TRAIL AND ANTIPROGESTINS FOR TREATING CANCER 审中-公开
标题翻译：使用TRAIL和抗病毒治疗癌症
公开(公告)号：WO02069995A3
公开(公告)日：2003-09-25
申请号：PCT/US0204712
申请日：2002-02-15
申请人： MED COLLEGE GEORGIA RES INST , KUMAR M VIJAY
发明人： KUMAR M VIJAY
IPC分类号： A61K38/17 , A61K45/06 , A61P35/00
CPC分类号： A61K45/06 , A61K31/573 , A61K38/177 , A61K2300/00
摘要： The present invention provides methods and compositions for treating cancer, and even more preferably, prostate cancer. In one aspect, the present invention comprises a method for inducing cell death in cancer cells comprising treating at least a portion of the cancer cells with an effective amount of TRAIL and an effective amount of an antiprogestin sufficient to induce apoptosis in at least a portion of the treated cancer cells. In another aspect, the present invention comprises a composition for treating cancer by inducing cell death in cancer cells comprising a pharmaceutical composition comprising an effective amount of TRAIL and an effective amount of an antiprogestin sufficient to induce apoptosis in at least a portion of the cancer cells exposed to the composition. In an embodiment, the antiprogestin is Mifepristone.
摘要翻译：本发明提供了用于治疗癌症，甚至更优选前列腺癌的方法和组合物。一方面，本发明包括在癌细胞中诱导细胞死亡的方法，包括用有效量的TRAIL和有效量的抗孕激素治疗至少一部分癌细胞，所述有效量的抗孕激素足以在至少一部分治疗的癌细胞。在另一方面，本发明包括通过在癌细胞中诱导细胞死亡来治疗癌症的组合物，其包含药物组合物，所述药物组合物包含有效量的TRAIL和有效量的抗孕激素，其足以在至少一部分癌细胞中诱导凋亡暴露于组合物。在一个实施方案中，抗孕激素是米非司酮。

3. 发明申请

WO2002069995A2 TREATMENT OF PROSTATE CANCER 审中-公开
标题翻译：治疗前列腺癌
公开(公告)号：WO2002069995A2
公开(公告)日：2002-09-12
申请号：PCT/US2002/004712
申请日：2002-02-15
申请人： MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC. , KUMAR, M., Vijay
发明人： KUMAR, M., Vijay
IPC分类号： A61K38/00
CPC分类号： A61K45/06 , A61K31/573 , A61K38/177 , A61K2300/00
摘要： The present invention provides methods and compositions for treating cancer, and even more preferably, prostate cancer. In one aspect, the present invention comprises a method for inducing cell death in cancer cells comprising treating at least a portion of the cancer cells with an effective amount of TRAIL and an effective amount of an antiprogestin sufficient to induce apoptosis in at least a portion of the treated cancer cells. In another aspect, the present invention comprises a composition for treating cancer by inducing cell death in cancer cells comprising a pharmaceutical composition comprising an effective amount of TRAIL and an effective amount of an antiprogestin sufficient to induce apoptosis in at least a portion of the cancer cells exposed to the composition. In an embodiment, the antiprogestin is Mifepristone.
摘要翻译：本发明提供了用于治疗癌症，甚至更优选前列腺癌的方法和组合物。一方面，本发明包括在癌细胞中诱导细胞死亡的方法，包括用有效量的TRAIL和有效量的抗孕激素治疗至少一部分癌细胞，所述有效量的抗孕激素足以在至少一部分治疗的癌细胞。在另一方面，本发明包括通过在癌细胞中诱导细胞死亡来治疗癌症的组合物，其包含药物组合物，所述药物组合物包含有效量的TRAIL和有效量的抗孕激素，其足以在至少一部分癌细胞中诱导凋亡暴露于组合物。在一个实施方案中，抗孕激素是米非司酮。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式